Extended lymph node dissection for prostate cancer

Jeschke, Stephan; Burkhard, Fiona C; Thurairaja, Ramesh; Dhar, Nivedita; Studer, Urs E (2008). Extended lymph node dissection for prostate cancer. Current urology reports, 9(3), pp. 237-242. Philadelphia, Pa.: Current Science

Full text not available from this repository. (Request a copy)

Lymph node status is an important determinant for the management of patients with newly diagnosed prostate cancer. Given the significant limitations of cross-sectional and functional preoperative imaging in the detection of small metastases, pelvic lymph node dissection remains the only reliable staging method in clinically localized prostate cancer. Although lymph node dissection is a well-established form of staging in prostate cancer, controversy remains about indications and the surgical extent of the procedure. Reported practices vary from omitting pelvic lymph node dissection in low-risk disease to routine pelvic lymph node dissection in all radical prostatectomy patients. This review highlights the recent literature concerning pelvic lymphadenectomy in prostate cancer with respect to anatomical extent and oncologic outcome.

Item Type:

Journal Article (Further Contribution)


04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Urology

UniBE Contributor:

Burkhard, Fiona C. and Studer, Urs






Current Science




Factscience Import

Date Deposited:

04 Oct 2013 15:04

Last Modified:

21 Jun 2016 14:34

PubMed ID:



https://boris.unibe.ch/id/eprint/27995 (FactScience: 115421)

Actions (login required)

Edit item Edit item
Provide Feedback